BIO-key International, Inc.
(Exact name of registrant as specified in its charter)
|
||
Delaware
(State or other jurisdiction of incorporation)
|
1-13463
(Commission File Number)
|
41-1741861
(I.R.S. Employer Identification No.)
|
3349 Highway 138, Building D, Suite B
Wall, NJ 07719
(Address of principal executive offices)
|
||
(732) 359-1100
(Registrant’s telephone number, including area code)
|
||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
|
(d) | Exhibits |
99.1 | Press Release, dated November 29, 2011, issued by the Company. |
BIO-KEY INTERNATIONAL, INC.
|
|||
Date: November 30, 2011
|
By:
|
/s/ Cecilia C. Welch | |
Cecilia C. Welch
|
|||
Chief Financial Officer
|
Exhibit No.
|
Description
|
99.1
|
Press Release, dated November 29, 2011, issued by the Company.
|